Eukles Asset Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-40
Closed -$4.4K 234
2023
Q4
$4.4K Hold
40
﹤0.01% 186
2023
Q3
$3.87K Hold
40
﹤0.01% 188
2023
Q2
$4.36K Hold
40
﹤0.01% 178
2023
Q1
$4.05K Hold
40
﹤0.01% 169
2022
Q4
$4K Hold
40
﹤0.01% 168
2022
Q3
$4K Hold
40
﹤0.01% 162
2022
Q2
$4K Hold
40
﹤0.01% 163
2022
Q1
$5K Hold
40
﹤0.01% 156
2021
Q4
$6K Hold
40
﹤0.01% 163
2021
Q3
$5K Sell
40
-1,160
-97% -$142K ﹤0.01% 156
2021
Q2
$139K Buy
1,200
+1,160
+2,900% +$135K 0.08% 112
2021
Q1
$5K Buy
+40
New +$4.74K ﹤0.01% 152

Other funds holding ABT

Eukles Asset Management's ABT Position: Q1 2024 in Review

Eukles Asset Management sold out of Abbott (ABT) in Q1 2024, closing a stake of 40 shares — an estimated $4.4K sold.

Eukles Asset Management first reported a position in ABT in Q1 2021 and held it in 12 quarters. The position peaked at $139K in Q2 2021. 2,904 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

  • Eukles Asset Management reported no remaining Abbott position as of Q1 2024 after selling out during the quarter.
  • Eukles Asset Management sold 40 Abbott shares in Q1 2024, an estimated $4.4K.
  • Eukles Asset Management first reported a position in Abbott in Q1 2021 and held it in 12 quarters.
  • Eukles Asset Management's Abbott position peaked at $139K in Q2 2021.
  • 2,904 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on Eukles Asset Management's 13F filing for Q1 2024, filed 13 May 2024.